Preventing, identifying, and managing cosmetic procedure complications, part 1: soft-tissue augmentation and botulinum toxin injections

Cutis. 2016 Jun;97(6):E28-9.

Abstract

This column highlights some of the potential complications that have been associated with cosmetic procedures. Tips for how dermatology residents may prevent, identify, and manage complications from cosmetic procedures for optimal patient outcomes is provided. In part 1 of this series, soft-tissue augmentation and botulinum toxin injections are discussed. Part 2 will focus on chemical peels and laser therapy.

MeSH terms

  • Adrenergic alpha-2 Receptor Agonists / therapeutic use
  • Blepharoptosis / chemically induced
  • Blepharoptosis / diagnosis
  • Blepharoptosis / drug therapy
  • Blepharoptosis / prevention & control
  • Botulinum Toxins / adverse effects*
  • Clonidine / analogs & derivatives
  • Clonidine / therapeutic use
  • Cosmetic Techniques / adverse effects*
  • Dermal Fillers / adverse effects*
  • Dermatologic Surgical Procedures / adverse effects*
  • Granuloma, Foreign-Body / diagnosis
  • Granuloma, Foreign-Body / prevention & control
  • Humans
  • Neurotoxins / adverse effects*
  • Postoperative Complications / diagnosis
  • Postoperative Complications / prevention & control*
  • Postoperative Complications / therapy
  • Surgical Wound Infection / diagnosis
  • Surgical Wound Infection / drug therapy
  • Surgical Wound Infection / prevention & control

Substances

  • Adrenergic alpha-2 Receptor Agonists
  • Dermal Fillers
  • Neurotoxins
  • apraclonidine
  • Botulinum Toxins
  • Clonidine